Our ability to turn great products into great medicines has never been more reliant on how we engage with our patients, yet we’re still falling short of expectations and failing to build sustainable trust with our communities, leading to lower adherence, slower trials and sub-optimal outcomes. Co-creation must be the lifeblood of your business, spanning …